Understand the key differences between hormone therapy and targeted therapy clinical trials and research opportunities
Blocks hormones that fuel certain cancers (breast, prostate). Long-established with well-understood side effect profiles. Often used as long-term maintenance.
Targets specific molecular features of cancer cells. Rapidly evolving field with new agents regularly entering trials. Requires genetic/molecular testing.
Hormone therapy is specific to hormone-sensitive cancers and is often long-term. Targeted therapy can apply to many cancer types based on molecular features.
Search our database of 29,000+ UK clinical trials matched to your condition and profile
Browse Disease PathwaysData sourced from ClinicalTrials.gov. Trial counts are approximate and updated regularly.
TrialConnect is a trading name of Clinical Vendor Compare Limited.